FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386474295> ?p ?o ?g. }

• W4386474295 endingPage "110894" @default.
• W4386474295 startingPage "110894" @default.
• W4386474295 abstract "Programmed cell death ligand-1 (PD-L1)is an antitumor immunity molecule and a great target to cure oral cancer; nonetheless, the limited success can be attributed to many complex pathways and tumor-related interferences.In the present study, 150 human oral squamous cell carcinoma (OSCC) tissue samples, including 17 adjacent normals, 56 primary tumors, 47 invasive tumors, and 30 therapy-resistant (RT) samples, were included. The parental/cisplatin-resistant (CisR-SCC4/9) cells were utilized for overexpression (Jak1-3 wild type and catalytically inactive), knockdown (PD-L1 siRNA), targeting MAPK/PI3K/Jak-Stat pathways (SMIs) and checking microsomes. The expression of PD-L1, transcription factors (TFs), signaling pathways, survival/apoptosis, therapy resistance, and invasiveness-related molecules/their activity were determined by RT-PCR, Immunohistochemistry, Western blot, Gelatin Zymography, and MTT assay.Advanced OSCC tumors (invasive and drug-resistance), CisR-SCC4/9 cells, and secretory exosomes (CisR-SCC4/9) were found with increased PD-L1 expression. PD-L1 mRNA/protein showed a positive correlation with different TFs (AP1 > Stat3 > c-myc > NFκB) in tumor samples. The PD-L1 expression was more influenced by Jak-Stat/ MAPK-AP1 pathways over PI3K. The ectopic expression of Jak1-3 suggests Jak2 inducted PD-L1 level over Jak1/Jak3. Finally, PD-L1 directly supports survival (Bcl-xL, Bax, cleaved caspase-3), invasion (MMP2/9), and drug-resistance (ALDH-1A1/-3A1) program in OSCC through its link with several molecules.PD-L1 was regulated mainly by the Jak2-Stat3/ MAPK-AP1 pathway, and besides the routine immunological functions, it supports OSCC survival, invasion, and therapy resistance. PD-L1 can be used as an indicator of severity and can be targeted along with Jak2-Stat3/ MAPK-AP1 for a better outcome OSCC." @default.
• W4386474295 created "2023-09-07" @default.
• W4386474295 creator A5018164154 @default.
• W4386474295 creator A5026586222 @default.
• W4386474295 creator A5031262268 @default.
• W4386474295 creator A5037409118 @default.
• W4386474295 creator A5044411309 @default.
• W4386474295 creator A5073070380 @default.
• W4386474295 creator A5075962165 @default.
• W4386474295 creator A5082302995 @default.
• W4386474295 date "2023-11-01" @default.
• W4386474295 modified "2023-10-18" @default.
• W4386474295 title "Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance" @default.
• W4386474295 cites W2063264144 @default.
• W4386474295 cites W2154817642 @default.
• W4386474295 cites W2176647747 @default.
• W4386474295 cites W2253000935 @default.
• W4386474295 cites W2274310825 @default.
• W4386474295 cites W2465860350 @default.
• W4386474295 cites W2516619560 @default.
• W4386474295 cites W2517381625 @default.
• W4386474295 cites W2590330461 @default.
• W4386474295 cites W2596871774 @default.
• W4386474295 cites W2609231980 @default.
• W4386474295 cites W2655262992 @default.
• W4386474295 cites W2738879667 @default.
• W4386474295 cites W2768353493 @default.
• W4386474295 cites W2771472591 @default.
• W4386474295 cites W2772391116 @default.
• W4386474295 cites W2793908502 @default.
• W4386474295 cites W2793992337 @default.
• W4386474295 cites W2887249435 @default.
• W4386474295 cites W2895328436 @default.
• W4386474295 cites W2896117726 @default.
• W4386474295 cites W2902000854 @default.
• W4386474295 cites W2904089156 @default.
• W4386474295 cites W2934922729 @default.
• W4386474295 cites W2939342954 @default.
• W4386474295 cites W2967520916 @default.
• W4386474295 cites W2973766991 @default.
• W4386474295 cites W2973887189 @default.
• W4386474295 cites W2981748756 @default.
• W4386474295 cites W2982693373 @default.
• W4386474295 cites W2996157116 @default.
• W4386474295 cites W3002787057 @default.
• W4386474295 cites W3004782363 @default.
• W4386474295 cites W3019768286 @default.
• W4386474295 cites W3034212817 @default.
• W4386474295 cites W3039239201 @default.
• W4386474295 cites W3044628240 @default.
• W4386474295 cites W3047048186 @default.
• W4386474295 cites W3047616340 @default.
• W4386474295 cites W3087384818 @default.
• W4386474295 cites W3092240599 @default.
• W4386474295 cites W3097379412 @default.
• W4386474295 cites W3105516986 @default.
• W4386474295 cites W3112811149 @default.
• W4386474295 cites W3128646645 @default.
• W4386474295 cites W3131847824 @default.
• W4386474295 cites W3135302840 @default.
• W4386474295 cites W3162226089 @default.
• W4386474295 cites W3169408085 @default.
• W4386474295 cites W3186597609 @default.
• W4386474295 cites W3205397345 @default.
• W4386474295 cites W3207461315 @default.
• W4386474295 cites W4200406295 @default.
• W4386474295 cites W4221028894 @default.
• W4386474295 cites W4280573173 @default.
• W4386474295 cites W4297250830 @default.
• W4386474295 cites W4310230929 @default.
• W4386474295 cites W4312129028 @default.
• W4386474295 doi "https://doi.org/10.1016/j.intimp.2023.110894" @default.
• W4386474295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37678027" @default.
• W4386474295 hasPublicationYear "2023" @default.
• W4386474295 type Work @default.
• W4386474295 citedByCount "0" @default.
• W4386474295 crossrefType "journal-article" @default.
• W4386474295 hasAuthorship W4386474295A5018164154 @default.
• W4386474295 hasAuthorship W4386474295A5026586222 @default.
• W4386474295 hasAuthorship W4386474295A5031262268 @default.
• W4386474295 hasAuthorship W4386474295A5037409118 @default.
• W4386474295 hasAuthorship W4386474295A5044411309 @default.
• W4386474295 hasAuthorship W4386474295A5073070380 @default.
• W4386474295 hasAuthorship W4386474295A5075962165 @default.
• W4386474295 hasAuthorship W4386474295A5082302995 @default.
• W4386474295 hasConcept C173396325 @default.
• W4386474295 hasConcept C190283241 @default.
• W4386474295 hasConcept C2778923194 @default.
• W4386474295 hasConcept C502942594 @default.
• W4386474295 hasConcept C54355233 @default.
• W4386474295 hasConcept C55493867 @default.
• W4386474295 hasConcept C57074206 @default.
• W4386474295 hasConcept C62478195 @default.
• W4386474295 hasConcept C81885089 @default.
• W4386474295 hasConcept C86803240 @default.
• W4386474295 hasConcept C95444343 @default.
• W4386474295 hasConcept C97037327 @default.
• W4386474295 hasConceptScore W4386474295C173396325 @default.

• next